Lili Fu

4.3k citations
86 papers · 3.2k indexed · 3 hit papers · h-index 25

Lili Fu

81 papers receiving 3.2k citations

Hit Papers

α-Klotho is a non-enzymatic molecular scaffold for FG...3632013202620172021250500750

Peers

Lili Fu
Comparison fields: 5 of 125
  • Nephrology 675
  • Biochemistry 227
  • Cancer Research 400
  • Genetics 739
  • Critical Care and Intensive Care Medicine 130
Replace Elena Galkina with:
Elena Galkina United States
Julia Carracedo Spain
Christian Rosenberger Germany
Michael M. Hoffmann Germany
José Rivera Spain
Kei Yamamoto Japan
Murray C.H. Clarke United Kingdom
Makiko Ueda Japan
Jun Peng China
Jin‐Yeong Han South Korea
Lili Fu relative to Elena Galkina United States Elena Galkina's profile →
Citations per field
00.5×4.5×
Elena Galkina · 1×
Citations per year

Countries citing papers authored by Lili Fu

Since Specialization
Citations

This map shows the geographic impact of Lili Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lili Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lili Fu more than expected).

Fields of papers citing papers by Lili Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lili Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lili Fu. The network helps show where Lili Fu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Lili Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lili Fu Line = papers co-authored together Lili Fu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20250
3 20239
4 20236
5 202368
6 20233
7 20222
8 20227
9 202036
10 201913
11
α-Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signallingbreakdown →
2018363
12 201717
13 201724
14 201526
15 201439
16 201425
17 201243
18 201160
19 20095
20 20087

About Lili Fu

Lili Fu is a scholar working on Nephrology, Genetics and Immunology, having authored 86 papers that have together received 3.2k indexed citations. Recurring topics across this work include Genetic and Kidney Cyst Diseases (19 papers), Renal and related cancers (11 papers), Biomedical Research and Pathophysiology (7 papers), Genetic Syndromes and Imprinting (5 papers), Dialysis and Renal Disease Management (5 papers), Hedgehog Signaling Pathway Studies (5 papers), Renal Diseases and Glomerulopathies (5 papers) and Kruppel-like factors research (5 papers). The work is most often cited by research in Nephrology (675 citations), Biochemistry (227 citations) and Cancer Research (400 citations). Lili Fu has collaborated with scholars based in China, United States and Saudi Arabia. Frequent co-authors include Changlin Mei, Xiang Gao, Xiangchen Gu, Bing Dai, Gaozhi Chen, Guang Liang, Xiaokun Li, Lijun Sun, Ming Wu and Moosa Mohammadi. Their work appears in journals such as Kidney & Blood Pressure Research, Investigational New Drugs, American Journal of Physiology-Renal Physiology, Drug Design Development and Therapy and International Journal of Molecular Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026